Status:

COMPLETED

The Standard Care Versus Celecoxib Outcome Trial

Lead Sponsor:

University of Dundee

Collaborating Sponsors:

University of Glasgow

University of Nottingham

Conditions:

Osteoarthritis

Rheumatoid Arthritis

Eligibility:

All Genders

60+ years

Phase:

PHASE4

Brief Summary

The Standard Care versus Celecoxib Outcome Trial (SCOT) is a large streamline safety study designed to compare the cardiovascular safety of celecoxib versus traditional non-selective Non Steroidal Ant...

Detailed Description

Aims The present proposal seeks to compare the cardiovascular and gastrointestinal safety and effectiveness of a strategy of initial randomisation to treatment with the selective COX-2 inhibitor cele...

Eligibility Criteria

Inclusion

  • Subjects 60 years or over Male \& Female
  • Chronic NSAIDs use for 90 days or more in a 12 month period
  • Subjects who have a licensed indication for chronic non-selective NSAID or Celecoxib.
  • Eligible for treatment with either Celecoxib or alternative traditional non-selective NSAID.
  • Subjects who are willing to consent to their paper and electronic medical records and prescribing data to be accessed.
  • Subjects who are willing to be contacted and interviewed by trial investigators.

Exclusion

  • Established cardiovascular disease including ischaemic heart disease, Myocardial Infarction, angina or acute coronary syndrome, cerebrovascular disease or cerebrovascular accident or transient ischaemic attack, established peripheral vascular disease and moderate to severe heart failure.

Key Trial Info

Start Date :

June 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2015

Estimated Enrollment :

7297 Patients enrolled

Trial Details

Trial ID

NCT00447759

Start Date

June 1 2007

End Date

August 1 2015

Last Update

May 3 2019

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

University of Southern Denmark

Odense, Denmark, 5000

2

Julius Clinical Research

Zeist, Netherlands, 3703 CD Zeist

3

University of Aberdeen

Aberdeen, United Kingdom, AB25 2ZN

4

University of Birmingham

Birmingham, United Kingdom, B15 2TT